← Evidence map

ArticleScientific reports2021

Nongenotoxic ABCB1 activator tetraphenylphosphonium can contribute to doxorubicin resistance in MX-1 breast cancer cell line.

Raimonda Kubiliute et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2021
2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33753859